Form 4: Stoke Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Alexander Cumbo, a Director of Stoke Therapeutics, Inc., received 39,674 shares of common stock on September 23, 2026.
Summary
- Grant/award: acquired 39,674 Director Stock Option (Right to Buy) on September 23, 2026; holds 39,674 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Alexander Cumbo — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-23 | Grant/award | Director Stock Option (Right to Buy) | 39,674 | — | — | 39,674 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-23 | Grant/award (39,674 shares) |
Keywords
insider transaction, Form 4, STOK, Stoke Therapeutics, Inc., neutral, Alexander Cumbo
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.